Paxlovid is a Kit in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .
| Product ID | 0069-0345_272bc07e-ee0a-48b5-8449-16a24da5670c |
| NDC | 0069-0345 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Paxlovid |
| Generic Name | Nirmatrelvir And Ritonavir |
| Dosage Form | Kit |
| Marketing Start Date | 2022-04-18 |
| Marketing Category | EMERGENCY USE AUTHORIZATION / |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-04-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-0345 | Paxlovid | nirmatrelvir and ritonavir |
| 0069-1085 | Paxlovid | nirmatrelvir and ritonavir |
| 0069-1101 | Paxlovid | nirmatrelvir and ritonavir |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PAXLOVID 90642654 not registered Live/Pending |
Pfizer Inc. 2021-04-13 |